13F reference period
Q2 2026
Security Snapshot
AETHLON MEDICAL INC - Common stock, par value $0.0001 per share (AEMD) Institutional Ownership
CUSIP: 00808Y604
13F Institutional Holders and Ownership History from Q3 2025 to Q3 2026
Institutions Reporting
17
Shares (Excl. Options)
265.82K
Full value: 265,820 · shares · 30 Jun 2026Price
$0.82
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common stock, par value $0.0001 per share
- Symbol
- AEMD on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 265,820
- Total 13F value
- $218,073
- Portfolio coverage rank
- 0%
- Share change
- +195,037
- Value change
- +$141,547
- Number of holders
- 17
- Shares outstanding
- 845,806
- SEC-reported price per share
- $0.66
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- AEMD - AETHLON MEDICAL INC - Common stock, par value $0.0001 per share is tracked under CUSIP 00808Y604.
- 17 institutions reported positions in Q2 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 12 to 17 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$155.02K
Full value: $155,016 · USD · 31 Mar 2026.$218.07K
Full value: $218,073 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 17 institutions filings for Q2 2026.
Security key
00808Y604
13F reference period
Q2 2026
13F holders
17
13D/G owners
1
CIK / CUSIP context first
Open Q2 2026 holders
AEMD full holder history
AETHLON MEDICAL INC SEC filings
AETHLON MEDICAL INC company facts
AETHLON MEDICAL INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 00808Y604:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
AEMD
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 10% | $254,333 | 84,496 | Armistice Capital, LLC | 31 Dec 2025 |
As of 30 Jun 2026,
17
institutional investors reported holding
shares of
AETHLON MEDICAL INC - Common stock, par value $0.0001 per share (AEMD).
This represents
31%
of the company’s total
outstanding shares.
265.82K
Full value: 265,820 · shares · 30 Jun 2026845.81K
Full value: 845,806 · shares · Stored outstanding share count13F concentration
Top 19 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
31%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| HRT FINANCIAL LP | 8.6% | 72,743 | 0% | $59,000 | |
| CITADEL ADVISORS LLC | 5.1% | 42,977 | 0% | $35,387 | |
| JANE STREET GROUP, LLC | 4.6% | 38,880 | 0% | $32,014 | |
| Shay Capital LLC | 3.7% | 31,072 | +120% | 0% | $25,585 |
| Virtu Financial LLC | 3.3% | 27,815 | 0% | $23,000 | |
| Ikarian Capital, LLC | 1.7% | 14,364 | 0% | 0% | $11,827 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.2% | 10,189 | -58% | 0% | $8,389 |
| Scientech Research LLC | 1.2% | 10,054 | 0.01% | $8,278 | |
| UBS Group AG | 1% | 8,876 | +892% | 0% | $7,305 |
| Tower Research Capital LLC (TRC) | 0.75% | 6,331 | +293% | 0% | $5,213 |
| MORGAN STANLEY | 0.29% | 2,472 | +21% | 0% | $2,035 |
| JONES FINANCIAL COMPANIES LLLP | 0% | 17 | 0% | $15 | |
| GROUP ONE TRADING LLC | 0% | 14 | 0% | 0% | $12 |
| BlackRock, Inc. | 0% | 10 | 0% | 0% | $8 |
| WELLS FARGO & COMPANY/MN | 0% | 3 | 0% | 0% | $2 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 0% | 2 | 0% | $2 | |
| DANSKE BANK A/S | 0% | 1 | 0% | 0% | $1 |
| XTX Topco Ltd | 0% | 0 | -100% | $0 | |
| Caitong International Asset Management Co., Ltd | 0% | 0 | -100% | $0 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
5
Headline period
Q2 2026
Rows shown
1-5 of 5